Navigation Links
China Aoxing Pharmaceutical Designated as a Key Manufacturer of Cancer Pain Drug by China SFDA
Date:11/26/2007

Company to address significant unmet medical needs in cancer pain

management

NEW YORK, Nov. 26 /PRNewswire-FirstCall/ -- China Aoxing Pharmaceutical Company, Inc. (OTC Bulletin Board: CAXG), which has the largest manufacturing facility and product pipeline for highly regulated narcotic medicines and pain medication in China, today announced that the China State Food & Drug Administration (SFDA) granted the Company the designated manufacturer status to produce Tilidine Tablets and Capsules, a highly regulated narcotic drug, in order to address significant unmet medical needs in cancer pain management in China.

Mr. Zhenjiang Yue, the CEO of CAXG, said: "We are very pleased with the SFDA's decision on designating the Company as the only drug manufacturer for this highly regulated cancer pain medicine in China. We expect to launch this important and needed cancer pain medicine through CAXG's integrated 500 person sales force in later 2008. Cancer pain management is a key component in oncology therapy, and becomes the top priority for terminal cancer patients. Cancer has become the first cause of death in China, estimated at 1.5 million victims per year. The number of victims is soaring especially in rural and western China as Western diet and lifestyle becomes prevalent. China's government and medical community are fully aware that China is woefully behind the rest of world in cancer pain treatment. For example, the consumption of morphine for pain per capita only amounts to 1/3 of other developing countries, more strikingly, almost 0.5% of developed countries. Our mission is to bring multiple effective therapeutic options, including Oxycodone, Tilidine and other promising narcotic pain medicines in our pipeline, to help approximately 20 million cancer patients in China."

Ms. Liying Yang, the Vice President of R&D, commented, "Today's approval continues reflecting the trust and support from the China SFDA,
'/>"/>

SOURCE China Aoxing Pharmaceutical Company, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... 27, 2015 , ... The Kansas City Animal Health Investment ... health companies to hear from animal health companies with the newest technology. Companies ... agreements or distribution contracts. This meeting is one of the only investment ...
(Date:8/27/2015)... , Aug. 27, 2015 The National ... patient,s eyes—and life—were saved by doctors at Vanderbilt University ... with NNFF, NovaBay Pharmaceuticals and Dr. John Crew ... at Seton Medical Center in Daly ... used a breakthrough approach, pioneered by Dr. Crew, that ...
(Date:8/27/2015)... August 27, 2015 GlassesOff (OTCBB: GLSO), ... functions in the human vision system, announced today a partnership ... guard Chris Paul to develop a new mobile ... to improve their real-life on-court performance. Vision is ... it is shooting a ball or blocking a pass. The ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... Medicine, recently presented new data on the relationship of genetics and hypertension at ... Congress on Heart Disease in Vancouver, British Columbia, Canada. The event, which boasts ...
Breaking Biology Technology:VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 2Patient's Life and Eyes Saved from Gruesome Flesh-Eating Infection Consuming Her Face 3Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3
... Joseph Fox 1 , Joanne B. Connolly ... 1 Shimadzu Scientifi c Inc., Columbia, US; ... , Introduction , ... no separation) acquisitions for the analysis of complex peptide mixtures. These include (i) ...
... Introduction , ... serial,dilution of reagents or compounds. IC 50 assays,are commonly used to ... the serial dilution,of proteins, compounds, or other detection,agents. These processes can be ... , , ...
... Introduction , ... ODS-100V and TSKgel ODS-100Z, excellent chromatographic performance and , ... sample types. TSKgel ODS-100Z , and TSKgel ODS-100V ... with 100 angstrom pores; each material is derivatized with difunctional , ...
Cached Biology Technology:LC-MALDI and MALDI-MS/MS for the Analysis of Complex Peptide Mixtures 2LC-MALDI and MALDI-MS/MS for the Analysis of Complex Peptide Mixtures 3LC-MALDI and MALDI-MS/MS for the Analysis of Complex Peptide Mixtures 4Serial Dilution with the Bravo Liquid Handling Platform 2Serial Dilution with the Bravo Liquid Handling Platform 3Serial Dilution with the Bravo Liquid Handling Platform 4Serial Dilution with the Bravo Liquid Handling Platform 5Serial Dilution with the Bravo Liquid Handling Platform 6Serial Dilution with the Bravo Liquid Handling Platform 7Serial Dilution with the Bravo Liquid Handling Platform 8Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins 2Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins 3
(Date:8/12/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced that four of its fingerprint ID products, ... been named FIDO Certified™ by the Fast IDentity ... Synaptics, Natural ID™ fingerprint solutions are fully compliant ... standard and are interoperable among other products and ...
(Date:8/6/2015)... REDWOOD CITY, Calif. , Aug. 6, 2015 ... (D-Silicon Valley) will visit Crossmatch ™ to ... secure networks and protect data. Crossmatch is a ... solutions whose technologies and expertise are helping federal ... operational efficiency and security.   "The ...
(Date:8/5/2015)... , August 5, 2015 Transparency ... "Facial Recognition Market - Global Industry Analysis, Size, Share, ... market for facial recognition is forecast to reach US$ ... increased demand for surveillance systems by civil and government ... of crimes and terrorist activities across the globe that ...
Breaking Biology News(10 mins):Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3Rep. Honda to Visit Crossmatch in Redwood City 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 2Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 3Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 4Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 5Facial Recognition Market Expected to Reach US$ 2.67 Bn by 2022, at a CAGR of 9.5% From 2015 - 2022: Transparency Market Research 6
... upset by a social snubbing? Your genetics, not your friends, ... opium-like painkillers, called opioids, relieve not only physical pain, but ... reviewed by Faculty of 1000 Biology member Markus Heilig shows ... receptor can determine the intensity of people,s responses to social ...
... low in Antarctic snowmelt that occurred during the 2008-09 austral ... two main climate drivers, ENSO (El Nio - Southern Oscillation) ... Tedesco, Assistant Professor of Earth & Atmospheric Sciences at The ... who is also on the doctoral faculty at the CUNY ...
... within minutes after waking up have much higher levels of ... than those who wait to smoke, regardless of the number ... appear to reflect the risk of lung cancer, our results ... especially at risk for lung cancer," said researcher Joshua E. ...
Cached Biology News:CCNY professor foresees rising Antarctic snowmelt 2Increased nicotine levels detected in those who light-up earlier 2
... VIP (6-28) (human, bovine, porcine, ... Peptide (VIP) receptor antagonist. This ... to be twofold more potent ... receptor antagonists. ...
Protein 3D structure prediction, via threading. Easy to use....
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
ANTI 5-HYDROXYTRYPTOPHAN CONJ....
Biology Products: